ACSS Consortium welcomes the U.K. as its newest member
15. October 2020 – The Medicines and Healthcare products Regulatory Authority (MHRA) is the therapeutic products regulator of the United Kingdom. MHRA will join Australia-Canada-Singapore-Switzerland (ACSS) Consortium as a full member from 1 January 2021. To accommodate the new partner, the group changed its name from ACSS Consortium to Access Consortium.
For further information, see here.